Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay-Reference-Cited by-同舟云学术

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay

Published:2016-02-01 Issue:2 Volume:11 Page:e0146474
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mouttet D.,Laé M.,Caly M.,Gentien D.,Carpentier S.,Peyro-Saint-Paul H.,Vincent-Salomon A.,Rouzier R.,Sigal-Zafrani B.,Sastre-Garau X.,Reyal F.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Immunohistochemical assessment of hormone receptor status of breast carcinoma: interobserver variation of the quick score;L Mudduwa;Indian J Med Sci,2009

2. Estrogen and progesterone receptor assay in paraffin-embedded breast cancer—reproducibility of assessment;G Chebil;Acta Oncol,2003

3. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems;A Rhodes;J Clin Pathol,2000

4. Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays;K Arihiro;Am J Clin Pathol,2007

5. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1–98;G Viale;J Clin Oncol,2007

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer;Medicina;2024-06-07

2. High expression of SULF1 is associated with adverse prognosis in breast cancer brain metastasis;Animal Models and Experimental Medicine;2024-04-08

3. Gene Expression Profile Prediction under Drug Action Based on Generative Adversarial Networks;2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM);2023-12-05

4. Risk factors and survival of triple‐negative breast cancer among breast cancer patients: Ten‐year cross‐sectional study in the southwestern Iranian population;Health Science Reports;2023-12

5. Unveiling the Power of Anticancer Drug Screening: A Clinical Case Study Comparing the Effectiveness of Hollow Fiber Assay Microtube Array Membrane (MTAM-HFA) in Breast Cancer Patients;Cancers;2023-05-15